Fecal microbiota transplantation
Fecal microbiota transplantation (FMT) represents the most promising free-antibiotic therapy in the management of patients with infection by Clostridium difficile, recurrent or refractory to treatment with antibiotics. FMT’s superiority over conventional treatment has been proven in multiple seri...
Autores principales: | , , , |
---|---|
Formato: | Artículo |
Lenguaje: | inglés |
Publicado: |
UANL. Facultad de Medicina
2015
|
Materias: | |
Acceso en línea: | http://eprints.uanl.mx/11660/1/S1665579615000605_S300_en.pdf |
_version_ | 1838550983857143808 |
---|---|
author | González Altamirado, J. Maldonado Garza, Héctor Jesús Garza González, Elvira Bosques Padilla, Francisco Javier |
author_facet | González Altamirado, J. Maldonado Garza, Héctor Jesús Garza González, Elvira Bosques Padilla, Francisco Javier |
author_sort | González Altamirado, J. |
collection | Repositorio Institucional |
description | Fecal microbiota transplantation (FMT) represents the most
promising free-antibiotic therapy in the management of
patients with infection by Clostridium difficile, recurrent
or refractory to treatment with antibiotics. FMT’s superiority over conventional treatment has been proven in multiple series of cases and recently in experimental prospective randomized clinical trials with a resolution of the infection in over 90% of patients |
format | Article |
id | eprints-11660 |
institution | UANL |
language | English |
publishDate | 2015 |
publisher | UANL. Facultad de Medicina |
record_format | eprints |
spelling | eprints-116602025-07-23T15:46:53Z http://eprints.uanl.mx/11660/ Fecal microbiota transplantation González Altamirado, J. Maldonado Garza, Héctor Jesús Garza González, Elvira Bosques Padilla, Francisco Javier RB Patología Fecal microbiota transplantation (FMT) represents the most promising free-antibiotic therapy in the management of patients with infection by Clostridium difficile, recurrent or refractory to treatment with antibiotics. FMT’s superiority over conventional treatment has been proven in multiple series of cases and recently in experimental prospective randomized clinical trials with a resolution of the infection in over 90% of patients UANL. Facultad de Medicina 2015 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/11660/1/S1665579615000605_S300_en.pdf http://eprints.uanl.mx/11660/1.haspreviewThumbnailVersion/S1665579615000605_S300_en.pdf González Altamirado, J. y Maldonado Garza, Héctor Jesús y Garza González, Elvira y Bosques Padilla, Francisco Javier (2015) Fecal microbiota transplantation. Medicina universitaria, 17 (68). pp. 192-194. ISSN 1665-5796 |
spellingShingle | RB Patología González Altamirado, J. Maldonado Garza, Héctor Jesús Garza González, Elvira Bosques Padilla, Francisco Javier Fecal microbiota transplantation |
thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
title | Fecal microbiota transplantation |
title_full | Fecal microbiota transplantation |
title_fullStr | Fecal microbiota transplantation |
title_full_unstemmed | Fecal microbiota transplantation |
title_short | Fecal microbiota transplantation |
title_sort | fecal microbiota transplantation |
topic | RB Patología |
url | http://eprints.uanl.mx/11660/1/S1665579615000605_S300_en.pdf |
work_keys_str_mv | AT gonzalezaltamiradoj fecalmicrobiotatransplantation AT maldonadogarzahectorjesus fecalmicrobiotatransplantation AT garzagonzalezelvira fecalmicrobiotatransplantation AT bosquespadillafranciscojavier fecalmicrobiotatransplantation |